SCHEMBL11684240

SCHEMBL11684240

O=C(Oc1nc2ccccc2s1)C(=O)Oc1nc2ccccc2s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.56
CYP1A2 P05177 3/20 0.56
CYP2C19 P33261 2/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
ALDH1A1 P00352 1/20 0.51
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
ALOX15 P16050 2/20 0.47
TSHR P16473 2/20 0.47
CASP1 P29466 1/20 0.47
ADORA1 P30542 1/20 0.47
DYRK1A Q13627 1/20 0.47
GAA P10253 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
PTGS1 P23219 3/20 0.46
PTGS2 P35354 3/20 0.46
POLB P06746 2/20 0.46
APEX1 P27695 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6006301 0.91 SMN1; SMN2 (0.56) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL10572642 0.90 CYP1A2 (0.51) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL10720726 0.89 SMN1; SMN2 (0.56) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL8795722 0.87 SMN1; SMN2 (0.59) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL21629502 0.87 SMN1; SMN2 (0.55) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL8795716 0.87 SMN1; SMN2 (0.55) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL20509384 0.86 SMN1; SMN2 (0.54) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL10535907 0.86 SMN1; SMN2 (0.54) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL5131881 0.86 CYP1A2 (0.56) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6
SCHEMBL6632291 0.86 CYP1A2 (0.54) SMN1; SMN2CYP1A2CYP2C19CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103228643-B As the benzoxazole derivative of histamine h 4 receptor part BIOPROJET (FR) 2015-11-25 CN disclosed
CN-103228643-A Benzazole derivatives as histamine H4 receptor ligands BIOPROJET SOC CIV 2013-07-31 CN disclosed
CN-1143364-A 5-HT3 receptor agonist, novel thiazole derivative, and intermediate thereof YAMANOUCHI PHARMA CO LTD (JP) 1997-02-19 CN disclosed
US-4028323-A WITH A SUBSTITUTED AMINOBENZENE CIBA-GEIGY AG (CH) 1977-06-07 US disclosed